Erk1/2 were reported to be phosphorylated on T207/188 in human patients and mouse models of cardiac hypertrophy and on intrinsically active Erk1/2 molecules mutated at R84/65 (10, 11). The gene discussed is MAPK3; the disease is cardiac hypertrophy.